review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/S000180050091 |
P698 | PubMed publication ID | 9368668 |
P2093 | author name string | Dang QD | |
Di Cera E | |||
Ayala YM | |||
P433 | issue | 9 | |
P304 | page(s) | 701-730 | |
P577 | publication date | 1997-09-01 | |
P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
P1476 | title | Molecular mechanisms of thrombin function | |
P478 | volume | 53 |
Q41818930 | 3-Nitrotyrosine as a spectroscopic probe for investigating protein protein interactions |
Q33990987 | A compare-and-contrast NMR dynamics study of two related RRMs: U1A and SNF. |
Q45213010 | A critical role for Gly25 in the B chain of human thrombin. |
Q33565369 | A molecular mechanism for signaling between seven-transmembrane receptors: evidence for a redistribution of G proteins |
Q35981965 | Allosteric Partial Inhibition of Monomeric Proteases. Sulfated Coumarins Induce Regulation, not just Inhibition, of Thrombin. |
Q45998339 | Allosteric regulation of the cofactor-dependent serine protease coagulation factor VIIa. |
Q44787689 | Alpha-keto amide peptides: a synthetic strategy to resin-bound peptide isosteres for protease inhibitor screening on solid support |
Q46108118 | Alpha-ketoamides and alpha-ketocarbonyls: conformational analysis and development of all-atom OPLS force field |
Q43581648 | An extensive interaction interface between thrombin and factor V is required for factor V activation |
Q51708222 | Anticoagulant thrombins. |
Q77296407 | Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II |
Q41429084 | Characterization of thrombin derived from human recombinant prothrombin |
Q34169141 | Cl- regulates the structure of the fibrin clot |
Q58453211 | Cl− and F− anions regulate the architecture of protofibrils in fibrin gel |
Q53340360 | Comparative blood coagulation studies in the ostrich. |
Q43754806 | Conformational changes in thrombin when complexed by serpins |
Q45293182 | Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery |
Q27639560 | Crystal structure of the anticoagulant slow form of thrombin |
Q54456467 | Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. |
Q29040782 | Designing Allosteric Regulators of Thrombin. Exosite 2 Features Multiple Subsites That Can Be Targeted by Sulfated Small Molecules for Inducing Inhibition |
Q42156369 | Effect of Na+ binding on the conformation, stability and molecular recognition properties of thrombin |
Q44562077 | Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin |
Q74485125 | Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II |
Q36884329 | Exosites in the substrate specificity of blood coagulation reactions |
Q36538526 | Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation |
Q36026736 | High Level Expression and Purification of Recombinant Proteins from Escherichia coli with AK-TAG. |
Q33382168 | How Na+ activates thrombin--a review of the functional and structural data |
Q34192168 | Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis |
Q36519387 | Incorporation of the fluorescent amino acid 7-azatryptophan into the core domain 1-47 of hirudin as a probe of hirudin folding and thrombin recognition |
Q54957197 | Investigation of Interactions between Thrombin and Ten Phenolic Compounds by Affinity Capillary Electrophoresis and Molecular Docking. |
Q47581912 | Molecular dissection of Na+ binding to thrombin. |
Q74527941 | Molecular mapping of thrombin-receptor interactions |
Q51810799 | Murine thrombin lacks Na+ activation but retains high catalytic activity. |
Q27657884 | Mutant N143P Reveals How Na+ Activates Thrombin |
Q73007036 | Mutations in autolytic loop-2 and at Asp554 of human prothrombin that enhance protein C activation by meizothrombin |
Q27652506 | Na+ binding to meizothrombin desF1 |
Q58453199 | Nanocavities trapped along fibrin fibers allow the diffusion of thrombolytic drugs |
Q46936908 | Ostrich antithrombin III: kinetics and mechanism of inhibition of ostrich thrombin |
Q60265904 | Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin. |
Q38251303 | Prolinamide derivatives as thrombin inhibitors for the treatment of thrombin-mediated diseases: a patent evaluation of US2013296245. |
Q30604793 | Proton bridging in the interactions of thrombin with hirudin and its mimics |
Q33567518 | Proton bridging in the interactions of thrombin with small inhibitors |
Q73343391 | Purification and characterization of ostrich prothrombin |
Q33857528 | Regulation of blood coagulation |
Q36610450 | Role of Na+ and K+ in enzyme function |
Q33177672 | Role of P225 and the C136-C201 disulfide bond in tissue plasminogen activator |
Q73626480 | Role of proexosite I in factor Va-dependent substrate interactions of prothrombin activation |
Q44562081 | Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin |
Q32060283 | Screening the molecular surface of human anticoagulant protein C: a search for interaction sites |
Q48007250 | Site-specific analysis of mutational effects in proteins. |
Q33585640 | Small, noncovalent serine protease inhibitors |
Q47884203 | Sputtering gold nanoparticles on nanoporous bismuth vanadate for sensitive and selective photoelectrochemical aptasensing of thrombin |
Q73754997 | Streptokinase binds to human plasmin with high affinity, perturbs the plasmin active site, and induces expression of a substrate recognition exosite for plasminogen |
Q27622194 | Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex |
Q27644424 | Structural basis of Na+ activation mimicry in murine thrombin |
Q43643277 | Structural features of a snake venom thrombin-like enzyme: thrombin and trypsin on a single catalytic platform? |
Q33509504 | Structure-based predictive models for allosteric hot spots |
Q33977957 | Synthesis and biochemical evaluation of triazole/tetrazole-containing sulfonamides against thrombin and related serine proteases |
Q73019212 | The C-terminal sequence encodes function in serine proteases |
Q27617975 | The crystal structure of α-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode |
Q62085857 | The effect of anions on azide binding to myoglobin: an unusual functional modulation |
Q45159617 | The effect of cations on the amidase activity of human tissue kallikrein: 1-linear competitive inhibition by sodium, potassium, calcium and magnesium. 2-linear mixed inhibition by aluminium |
Q43587867 | Thermodynamics of Na+ binding to coagulation serine proteases |
Q36800534 | Thrombin |
Q84684189 | Thrombin allosteric modulation revisited: a molecular dynamics study |
Q34291931 | Thrombin domains: structure, function and interaction with platelet receptors |
Q39252052 | Thrombin-induced CCN2 expression in human lung fibroblasts requires the c-Src/JAK2/STAT3 pathway. |
Q45176583 | Thrombomodulin changes the molecular surface of interaction and the rate of complex formation between thrombin and protein C. |
Q38289988 | Through-bond effects in the ternary complexes of thrombin sandwiched by two DNA aptamers. |
Q46391424 | Turn-on colorimetric sensor for ultrasensitive detection of thrombin using fibrinogen-gold nanoparticle conjugate. |
Q45865558 | Type II protein C deficiency: identification and molecular modelling of two natural mutants with low anticoagulant and normal amidolytic activity. |
Q97653055 | Validation of a stroke model in rat compatible with rt-PA-induced thrombolysis: new hope for successful translation to the clinic |
Search more.